Differential impact of methylphenidate and atomoxetine on sustained attention in youth with attention-deficit/hyperactivity disorder

Journal of Child Psychology and Psychiatry and Allied Disciplines

Volumn 56, Issue 1, 2015, Pages 40-48

  Bédard, Anne Claude V ^a   Stein, Mark A ^b   Halperin, Jeffrey M ^a,c   Krone, Beth ^a   Rajwan, Estrella ^c   Newcorn, Jeffrey H ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c CITY UNIVERSITY OF NEW YORK   (United States)

Author keywords

atomoxetine; attention; Attention deficit hyperactivity disorder; methylphenidate; vigilance

Indexed keywords

ADRENERGIC RECEPTOR AFFECTING AGENT; ATOMOXETINE; CENTRAL STIMULANT AGENT; METHYLPHENIDATE; PROPYLAMINE;

ADOLESCENT; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CHILD; COMPARATIVE STUDY; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; EXECUTIVE FUNCTION; FEMALE; HUMAN; INHIBITION (PSYCHOLOGY); MALE; PSYCHOMOTOR PERFORMANCE; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ADOLESCENT; ADRENERGIC UPTAKE INHIBITORS; ATOMOXETINE HYDROCHLORIDE; ATTENTION; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; EXECUTIVE FUNCTION; FEMALE; HUMANS; INHIBITION (PSYCHOLOGY); MALE; METHYLPHENIDATE; PROPYLAMINES; PSYCHOMOTOR PERFORMANCE; TREATMENT OUTCOME;

EID: 84919839591     PISSN: 00219630     EISSN: 14697610     Source Type: Journal    
DOI: 10.1111/jcpp.12272     Document Type: Article

References (50)

1. Barry, R.J., Clarke, A.R., Hajos, M., McCarthy, R., Selikowitz, M., &, Bruggemann, J.M., (2009). Acute atomoxetine effects on the EEG of children with attention-deficit/hyperactivity disorder. Neuropharmacology, 57, 702-707.
2. Bedard, A.C., Jain, U., Johnson, S.H., &, Tannock, R., (2007). Effects of methylphenidate on working memory components: Influence of measurement. Journal of Child Psychology and Psychiatry, 48, 872-880.
3. Berridge, C.W., Devilbiss, D.M., Andrzejewski, M.E., Arnsten, A.F., Kelley, A.E., Schmeichel, B.,... &, Spencer, R.C., (2006). Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Biological Psychiatry, 60, 1111-1120.
4. Bolden-Watson, C., &, Richelson, E., (1993). Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomes. Life Sciences, 52, 1023-1029.
5. Bymaster, F.P., Katner, J.S., Nelson, D.L., Hemrick-Luecke, S.K., Threlkeld, P.G., Heiligenstein, J.H.,... &, Perry, K.W., (2002). Atomoxetine increases extracellular levels of norepinephrine and dopamine in prefrontal cortex of rat: A potential mechanism for efficacy in attention deficit/hyperactivity disorder. Neuropsychopharmacology, 27, 699-711.
6. Chamberlain, S.R., Del Campo, N., Dowson, J., Muller, U., Clark, L., Robbins, T.W.,... &, Sahakian, B.J., (2007). Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder. Biological Psychiatry, 62, 977-984.
7. Chamberlain, S.R., Hampshire, A., Muller, U., Rubia, K., Campo, N.D., Craig, K.,... &, Sahakian, B.J., (2008). Atomoxetine modulates right inferior frontal activation during inhibitory control: A pharmacological functional magnetic resonance imaging study. Biological Psychiatry.
8. Chamberlain, S.R., Hampshire, A., Muller, U., Rubia, K., Del Campo, N., Craig, K.,... &, Sahakian, B.J., (2009). Atomoxetine modulates right inferior frontal activation during inhibitory control: A pharmacological functional magnetic resonance imaging study. Biological Psychiatry, 65, 550-555.
9. Coghill, D.R., Rhodes, S.M., &, Matthews, K., (2007). The neuropsychological effects of chronic methylphenidate on drug-naive boys with attention-deficit/hyperactivity disorder. Biological Psychiatry, 62, 954-962.
10. Coghill, D.R., Seth, S., Pedroso, S., Usala, T., Currie, J., &, Gagliano, A., (2013). Effects of Methylphenidate on Cognitive Functions in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: Evidence from a Systematic Review and a Meta-Analysis. Biological Psychiatry, pii: S0006-3223 (13) 00911-6.
11. Conners, C.K., (2000). I. Multi Health Systems.
12. Conners, C.K., (2002). Forty years of methylphenidate treatment in Attention-Deficit/Hyperactivity Disorder. Journal of Attention Disorders, 6 (Suppl 1), S17-S30.
13. Conners, C.K., Epstein, J.N., March, J.S., Angold, A., Wells, K.C., Klaric, J.,... &, Wigal, T., (2001). Multimodal treatment of ADHD in the MTA: An alternative outcome analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 40, 159-167.
14. Dolan, G.P., Stone, D.H., &, Briggs, A.H., (2010). A systematic review of continuous performance task research in children prenatally exposed to alcohol. Alcohol and Alcoholism, 45, 30-38.
15. DuPaul, G.J., Power, T.J., Anastopoulos, A.D., &, Reid, R., (1998). ADHD rating scale-IV: Checklists, norms, and clinical interpretation. New York: The Guilford Press.
16. Epstein, J.N., Conners, C.K., Hervey, A.S., Tonev, S.T., Arnold, L.E., Abikoff, H.B.,... &, Wigal, T., (2006). Assessing medication effects in the MTA study using neuropsychological outcomes. Journal of Child Psychology and Psychiatry, 47, 446-456.
17. Faraone, S.V., &, Buitelaar, J., (2010). Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis. European Child and Adolescent Psychiatry, 19, 353-364.
18. Gamo, N.J., Wang, M., &, Arnsten, A.F., (2010). Methylphenidate and atomoxetine enhance prefrontal function through alpha2-adrenergic and dopamine D1 receptors. Journal of the American Academy of Child and Adolescent Psychiatry, 49, 1011-1023.
19. Gatley, S.J., Pan, D., Chen, R., Chaturvedi, G., &, Ding, Y.S., (1996). Affinities of methylphenidate derivatives for dopamine, norepinephrine and serotonin transporters. Life Sciences, 58, 231-239.
20. Gau, S.S., &, Shang, C.Y., (2010). Improvement of executive functions in boys with attention deficit hyperactivity disorder: An open-label follow-up study with once-daily atomoxetine. International Journal of Neuropsychopharmacology, 13, 243-256.
21. Graf, H., Abler, B., Freudenmann, R., Beschoner, P., Schaeffeler, E., Spitzer, M.,... &, Gron, G., (2010). Neural correlates of error monitoring modulated by atomoxetine in healthy volunteers. Biological Psychiatry.
22. de Jong, C.G., Van De Voorde, S., Roeyers, H., Raymaekers, R., Allen, A.J., Knijff, S.,... &, Sergeant, J.A., (2009). Differential effects of atomoxetine on executive functioning and lexical decision in attention-deficit/hyperactivity disorder and reading disorder. Journal of Child and Adolescent Psychopharmacology, 19, 699-707.
23. Kaufman, J., Birmaher, B., Brent, D., Rao, U.M.A., Flynn, C., &, Moreci, P,.,... &, Ryan, N,. (1997). Schedule for affective disorders and schizophrenia for school-age children-present and lifetime version (K-SADS-PL): Initial reliability and validity data. Journal of the American Academy of Child & Adolescent Psychiatry, 36, 980-988.
24. Kratz, O., Studer, P., Baack, J., Malcherek, S., Erbe, K., Moll, G.H., &, Heinrich, H., (2012). Differential effects of methylphenidate and atomoxetine on attentional processes in children with ADHD: An event-related potential study using the Attention Network Test. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 37, 81-89.
25. Kuntsi, J., Wood, A.C., Rijsdijk, F., Johnson, K.A., Andreou, P., Albrecht, B.,... &, Asherson, P., (2010). Separation of cognitive impairments in attention-deficit/hyperactivity disorder into 2 familial factors. Archives of General Psychiatry, 67, 1159-1167.
26. Liu, S.T., Tsai, F.J., Lee, W.T., Lee, C.M., Fan, P.C., Lin, W.S.,... &, Gau, S.S., (2011). Attentional processes and ADHD-related symptoms in pediatric patients with epilepsy. Epilepsy Research, 93, 53-65.
27. Losier, B.J., McGrath, P.J., &, Klein, R.M., (1996). Error patterns on the continuous performance test in non-medicated and medicated samples of children with and without ADHD: A meta-analytic review. Journal of Child Psychology and Psychiatry, 37, 971-987.
28. Marquand, A.F., De Simoni, S., O'Daly, O.G., Williams, S.C., Mourao-Miranda, J., &, Mehta, M.A., (2011). Pattern classification of working memory networks reveals differential effects of methylphenidate, atomoxetine, and placebo in healthy volunteers. Neuropsychopharmacology, 36, 1237-1247.
29. McCabe, S.E., &, West, B.T., (2013). Medical and nonmedical use of prescription stimulants: Results from a national multicohort study. Journal of the American Academy of Child and Adolescent Psychiatry, 52, 1272-1280.
30. McGee, R.A., Clark, S.E., &, Symons, D.K., (2000). Does the Conners' Continuous Performance Test aid in ADHD diagnosis? Journal of Abnormal Child Psychology, 28, 415-424.
31. Michelson, D., Allen, A.J., Busner, J., Casat, C., Dunn, D., Kratochvil, C.,... &, Harder, D., (2002). Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: A randomized, placebo-controlled study. American Journal of Psychiatry, 159, 1896-1901.
32. Moron, J.A., Brockington, A., Wise, R.A., Rocha, B.A., &, Hope, B.T., (2002). Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: Evidence from knock-out mouse lines. Journal of Neuroscience, 22, 389-395.
33. Nandam, L.S., Hester, R., Wagner, J., Cummins, T.D., Garner, K., Dean, A.J.,... &, Bellgrove, M.A., (2010). Methylphenidate But Not Atomoxetine or Citalopram Modulates Inhibitory Control and Response Time Variability. Biological Psychiatry.
34. Navarra, R., Graf, R., Huang, Y., Logue, S., Comery, T., Hughes, Z., &, Day, M., (2008). Effects of atomoxetine and methylphenidate on attention and impulsivity in the 5-choice serial reaction time test. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 32, 34-41.
35. Newcorn, J.H., Kratochvil, C.J., Allen, A.J., Casat, C.D., Ruff, D.D., Moore, R.J., &, Michelson, D., (2008). Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: Acute comparison and differential response. American Journal of Psychiatry, 165, 721-730.
36. Peterson, B.S., Potenza, M.N., Wang, Z., Zhu, H., Martin, A., Marsh, R.,... &, Yu, S., (2009). An FMRI study of the effects of psychostimulants on default-mode processing during Stroop task performance in youths with ADHD. American Journal of Psychiatry, 166, 1286-1294.
37. Pietrzak, R.H., Mollica, C.M., Maruff, P., &, Snyder, P.J., (2006). Cognitive effects of immediate-release methylphenidate in children with attention-deficit/hyperactivity disorder. Neuroscience and Biobehavioral Reviews, 30, 1225-1245.
38. Rapport, M.D., Denney, C., DuPaul, G.J., &, Gardner, M.J., (1994). Attention deficit disorder and methylphenidate: Normalization rates, clinical effectiveness, and response prediction in 76 children. Journal of the American Academy of Child and Adolescent Psychiatry, 33, 882-893.
39. Reinecke, M.A., Beebe, D.W., &, Stein, M.A., (1999). The third factor of the WISC-III: It's (probably) not freedom from distractibility. Journal of the American Academy of Child and Adolescent Psychiatry, 38, 322-328.
40. Riccio, C.A., Waldrop, J.J., Reynolds, C.R., &, Lowe, P., (2001). Effects of stimulants on the continuous performance test (CPT): Implications for CPT use and interpretation. Journal of Neuropsychiatry and Clinical Neurosciences, 13, 326-335.
41. Schulz, K.P., Fan, J., Bedard, A.C., Clerkin, S.M., Ivanov, I., Tang, C.Y.,... &, Newcorn, J.H., (2012). Common and unique therapeutic mechanisms of stimulant and nonstimulant treatments for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 69, 952-961.
42. Spencer, T., Biederman, J., Heiligenstein, J., Wilens, T., Faries, D., Prince, J.,... &, Zervas, S., (2001). An open-label, dose-ranging study of atomoxetine in children with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology, 11, 251-265.
43. Spencer, T., Biederman, J., Wilens, T., Prince, J., Hatch, M., Jones, J.,... &, Seidman, L., (1998). Effectiveness and tolerability of tomoxetine in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry, 155, 693-695.
44. Spencer, S.V., Hawk, L.W., Jr, Richards, J.B., Shiels, K., Pelham, W.E., Jr, &, Waxmonsky, J.G., (2009). Stimulant treatment reduces lapses in attention among children with ADHD: The effects of methylphenidate on intra-individual response time distributions. Journal of Abnormal Child Psychology, 37, 805-816.
45. Sprague, R.L., &, Sleator, E.K., (1977). Methylphenidate in hyperkinetic children: Differences in dose effects on learning and social behavior. Science, 198, 1274-1276.
46. Tabachnick, B.G., &, Fidell, L.S., (1989). Using multivariate statistics, 1989. Harper Collins. Tuan, PD A comment from the viewpoint of time series analysis. Journal of Psychophysiology, 3, 46-48.
47. Tomasi, D., Volkow, N.D., Wang, G.J., Wang, R., Telang, F., Caparelli, E.C.,... &, Fowler, J.S., (2011). Methylphenidate enhances brain activation and deactivation responses to visual attention and working memory tasks in healthy controls. Neuroimage, 54, 3101-3110.
48. Vaidya, C.J., Austin, G., Kirkorian, G., Ridlehuber, H.W., Desmond, J.E., Glover, G.H., &, Gabrieli, J.D., (1998). Selective effects of methylphenidate in attention deficit hyperactivity disorder: A functional magnetic resonance study. Proceedings of the National Academy of Sciences of the USA, 95, 14494-14499.
49. Volkow, N.D., Wang, G.J., Fowler, J.S., Logan, J., Franceschi, D., Maynard, L.,... &, Swanson, J.M., (2002). Relationship between blockade of dopamine transporters by oral methylphenidate and the increases in extracellular dopamine: Therapeutic implications. Synapse, 43, 181-187.
50. Yildiz, O., Sismanlar, S.G., Memik, N.C., Karakaya, I., &, Agaoglu, B., (2011). Atomoxetine and methylphenidate treatment in children with ADHD: the efficacy, tolerability and effects on executive functions. Child Psychiatry & Human Development, 42, 257-269.